Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 40 HER2-positive Breast Cancer 6 Neoplasm Metastasis 2 Inflammatory Breast Neoplasms 2 Colonic Neoplasms 2 Stomach Neoplasms 1 Solid Tumors 1 Resectable HER2-positive Breast Cancer 1 Patient Preference 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms 1 Invasive Breast Cancer 1 HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 HER2+ Breast Cancer 1 HER2 Positive Early Breast Cancer 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Early-stage or Locally Advanced HER2-positive Breast Cancer 1 Early or Locally Advanced HER2-positive Breast Cancer 1 Carcinoma, Ductal, Breast 1 Breast Diseases 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1 Advanced HER2+Breast Cancer 1 Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 56 Capecitabine 49 Fluorouracil 37 Cisplatin 37 S 1 (combination) 23 Paclitaxel 18 Docetaxel 18 Leucovorin 16 pembrolizumab 13 Irinotecan 12 apatinib 11 titanium silicide 9 XELOX 9 Trastuzumab 9 Nivolumab 9 Hyperthermic Intraperitoneal Chemotherapy 8 Epirubicin 8 Drug Therapy 8 Tegafur 7 Radiotherapy 6 Neoadjuvant Therapy 6 gimeracil 5 Surgical Procedures, Operative 5 Gastrectomy 5 Chemotherapy, Adjuvant 5 tislelizumab 4 S-1 plus cisplatin 4 Ramucirumab 4 zolbetuximab 3 sintilimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Stomach Neoplasms × pertuzumab × Clear all

NCT01774786 2020-12-30

JACOB

Hoffmann-La Roche

Phase 3 Completed

780 enrolled 24 charts

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡